These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9358196)

  • 21. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foregoing prophylaxis: better safe than sorry?
    Gaylord G
    Posit Living; 1999 Nov; 8(10):44. PubMed ID: 11367330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing opportunistic infections.
    Cheng B
    PI Perspect; 1995 May; (no 16):14-5. PubMed ID: 11362422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of preventing AIDS-related opportunistic infections.
    Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
    JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunistic infections: down but not out.
    Bishai WR; Chaisson RE
    Hopkins HIV Rep; 1999 Mar; 11(2):2, 7, 12. PubMed ID: 11366247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune reconstitution in several forms.
    Ball SC
    AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
    [No Abstract]   [Full Text] [Related]  

  • 27. Prophylaxis of opportunistic infections in adults and children with HIV infection.
    AIDS Inst Newsl; 1995 Jun; ():1-12. PubMed ID: 11367408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV: prevention of opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2005 Jun; (13):834-53. PubMed ID: 16135281
    [No Abstract]   [Full Text] [Related]  

  • 29. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.
    El-Sadr WM; Burman WJ; Grant LB; Matts JP; Hafner R; Crane L; Zeh D; Gallagher B; Mannheimer SB; Martinez A; Gordin F
    N Engl J Med; 2000 Apr; 342(15):1085-92. PubMed ID: 10766581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals.
    Faris MA; Raasch RH; Hopfer RL; Butts JD
    Ann Pharmacother; 1998 May; 32(5):564-73. PubMed ID: 9606478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on opportunistic infections.
    Proj Inf Perspect; 1997 Nov; (23):16-7. PubMed ID: 11365373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus.
    Ostroff SM; Spiegel RA; Feinberg J; Benson CA; Horsburgh CR
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S72-6. PubMed ID: 8547516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAC prophylaxis in the era of polypharmacy.
    Sawhney N
    WMJ; 1999; 98(3):46-8. PubMed ID: 10414219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physician's aggressive preventive therapy differs.
    AIDS Alert; 1995 Sep; 10(9):111-2. PubMed ID: 11362774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States.
    Asch SM; Gifford AL; Bozzette SA; Turner B; Mathews WC; Kuromiya K; Cunningham W; Andersen R; Shapiro M; Rastegar A; McCutchan JA
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):340-4. PubMed ID: 11707670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stopping preventive treatments.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jul; 12(7):9-10. PubMed ID: 11367080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection fighters. MAC prevention takes a holiday.
    TreatmentUpdate; 2000 Oct; 12(7):2-3. PubMed ID: 12132450
    [No Abstract]   [Full Text] [Related]  

  • 39. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
    Wright J
    Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection.
    Fichtenbaum CJ; Zackin R; Feinberg J; Benson C; Griffiths JK;
    AIDS; 2000 Dec; 14(18):2889-93. PubMed ID: 11153670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.